{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:10:49Z","timestamp":1779124249309,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"MOE | Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120240382"],"award-info":[{"award-number":["22120240382"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"MOE | Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120240228"],"award-info":[{"award-number":["22120240228"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"MOE | Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120250457"],"award-info":[{"award-number":["22120250457"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225035"],"award-info":[{"award-number":["82225035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32090032"],"award-info":[{"award-number":["32090032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82461160317"],"award-info":[{"award-number":["82461160317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32421002"],"award-info":[{"award-number":["32421002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"MOST | National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1302803"],"award-info":[{"award-number":["2022YFA1302803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022XD053"],"award-info":[{"award-number":["2022XD053"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","award":["2025-0554-ZD-05"],"award-info":[{"award-number":["2025-0554-ZD-05"]}],"id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) is a primary liver malignancy with high rates of morbidity and mortality, yet effective treatment options remain limited. Accumulating evidence indicates that large tumour suppressor kinase 1 (LATS1), a core kinase in the Hippo pathway, mediates the phosphorylation of downstream YAP\/TAZ, thereby suppressing HCC progression. Although LATS1 protein stability has been reported to be modulated by ubiquitination, the specific mechanism controlling LATS1 kinase activity remains unknown. Here, we identify USP25 as a deubiquitinase that regulates LATS1 activity, independent of LATS1 protein stability. We demonstrated that USP25 is overexpressed in HCC and that USP25 depletion significantly suppresses HCC cell and tumour growth. Mechanistically, USP25 catalyses the removal of K63-linked ubiquitin at K688 of LATS1, which disrupts LATS1-MOB1 complex formation and promotes YAP-mediated transcriptional activation. Furthermore, we successfully developed a cell-penetrating peptide that disrupts the USP25-LATS1 interaction, which increases p-YAP expression and synergizes with chemotherapy in xenograft and patient-derived organoid and xenograft models. Collectively, our findings reveal a mechanism through which USP25 regulates LATS1 activity and provide a potential therapeutic strategy for HCC treatment.<\/jats:p>","DOI":"10.1038\/s44319-026-00749-w","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:23:01Z","timestamp":1774452181000},"page":"2406-2433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation"],"prefix":"10.1038","volume":"27","author":[{"given":"Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuJuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZeShan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-4137","authenticated-orcid":false,"given":"Linhui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanqiong","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiakai","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2801-8849","authenticated-orcid":false,"given":"Jian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1360-1919","authenticated-orcid":false,"given":"Yunhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.24710","volume":"55","author":"SF Altekruse","year":"2012","unstructured":"Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE (2012) Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 55:476\u2013482","journal-title":"Hepatology"},{"key":"749_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06380-0","volume":"14","author":"A Behera","year":"2023","unstructured":"Behera A, Reddy ABM (2023) WWP1 E3 ligase at the crossroads of health and disease. Cell Death Dis 14:853","journal-title":"Cell Death Dis"},{"key":"749_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network (2017) Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169:1327\u20131341.e1323","journal-title":"Cell"},{"key":"749_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ebiom.2018.08.010","volume":"35","author":"M Chen","year":"2018","unstructured":"Chen M, Wu L, Tu J, Zhao Z, Fan X, Mao J, Weng Q, Wu X, Huang L, Xu M et al (2018) miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression. EBioMedicine 35:142\u2013154","journal-title":"EBioMedicine"},{"key":"749_CR5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1101\/gad.264234.115","volume":"29","author":"Q Chen","year":"2015","unstructured":"Chen Q, Zhang N, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H et al (2015) Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev 29:1285\u20131297","journal-title":"Genes Dev"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, Zhao F, Wang Z, Yang X, Jin M et al (2024) Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187:294\u2013311.e221","journal-title":"Cell"},{"key":"749_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham R, Hansen CG (2022) The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond) 136:197\u2013222","journal-title":"Clin Sci (Lond)"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"e908","DOI":"10.21769\/BioProtoc.908","volume":"3","author":"ME Durkin","year":"2013","unstructured":"Durkin ME, Qian X, Popescu NC, Lowy DR (2013) Isolation of mouse embryo fibroblasts. Bio Protoc 3:e908","journal-title":"Bio Protoc"},{"key":"749_CR9","first-page":"506","volume":"16","author":"ND Ferrante","year":"2020","unstructured":"Ferrante ND, Pillai A, Singal AG (2020) Update on the diagnosis and treatment of hepatocellular carcinoma. Gastroenterol Hepatol 16:506\u2013516","journal-title":"Gastroenterol Hepatol"},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","volume":"20","author":"K Fosgerau","year":"2015","unstructured":"Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20:122\u2013128","journal-title":"Drug Discov Today"},{"key":"749_CR11","doi-asserted-by":"publisher","first-page":"G196","DOI":"10.1152\/ajpgi.00077.2014","volume":"307","author":"JL Grijalva","year":"2014","unstructured":"Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K (2014) Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol 307:G196\u2013G204","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"749_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dev.045500","volume":"138","author":"G Halder","year":"2011","unstructured":"Halder G, Johnson RL (2011) Hippo signaling: growth control and beyond. Development 138:9\u201322","journal-title":"Development"},{"key":"749_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2006.03.244","volume":"345","author":"A Hergovich","year":"2006","unstructured":"Hergovich A, Schmitz D, Hemmings BA (2006) The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 345:50\u201358","journal-title":"Biochem Biophys Res Commun"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1073\/pnas.1101273108","volume":"108","author":"KC Ho","year":"2011","unstructured":"Ho KC, Zhou Z, She YM, Chun A, Cyr TD, Yang X (2011) Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc Natl Acad Sci USA 108:4870\u20134875","journal-title":"Proc Natl Acad Sci USA"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang J, Wu S, Barrera J, Matthews K, Pan D (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122:421\u2013434","journal-title":"Cell"},{"key":"749_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-62703-481-4_7","volume":"1031","author":"Y Lei","year":"2013","unstructured":"Lei Y (2013) Generation and culture of mouse embryonic fibroblasts. Methods Mol Biol 1031:59\u201364","journal-title":"Methods Mol Biol"},{"key":"749_CR17","doi-asserted-by":"publisher","first-page":"eabb2914","DOI":"10.1126\/scitranslmed.abb2914","volume":"13","author":"K Li","year":"2021","unstructured":"Li K, Zhang TT, Zhao CX, Wang F, Cui B, Yang ZN, Lv XX, Yeerjiang Z, Yuan YF, Yu JM et al (2021) Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. Sci Transl Med 13:eabb2914","journal-title":"Sci Transl Med"},{"key":"749_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403485","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Li L, Wang X, Zhao F, Yang Y, Zhou Y, Zhang J, Wang L, Jiang Z, Zhang Y et al (2024) USP25 elevates SHLD2-mediated DNA double-strand break repair and regulates chemoresponse in cancer. Adv Sci 11:e2403485","journal-title":"Adv Sci"},{"key":"749_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15752","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Luo K, Yin Y, Wu C, Deng M, Li L, Chen Y, Nowsheen S, Lou Z, Yuan J (2017) USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. Nat Commun 8:15752","journal-title":"Nat Commun"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1073\/pnas.1509968112","volume":"112","author":"D Lin","year":"2015","unstructured":"Lin D, Zhang M, Zhang MX, Ren Y, Jin J, Zhao Q, Pan Z, Wu M, Shu HB, Dong C et al (2015) Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proc Natl Acad Sci USA 112:11324\u201311329","journal-title":"Proc Natl Acad Sci USA"},{"key":"749_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Rev Dis Prim 7:6","journal-title":"Nat Rev Dis Prim"},{"key":"749_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1073\/pnas.0911427107","volume":"107","author":"L Lu","year":"2010","unstructured":"Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS et al (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 107:1437\u20131442","journal-title":"Proc Natl Acad Sci USA"},{"key":"749_CR23","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.15252\/embj.201695669","volume":"36","author":"K Luo","year":"2017","unstructured":"Luo K, Li Y, Yin Y, Li L, Wu C, Chen Y, Nowsheen S, Hu Q, Zhang L, Lou Z et al (2017) USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling. EMBO J 36:1434\u20131446","journal-title":"EMBO J"},{"key":"749_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos GK, Bhushan B (2021) Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol 18:40\u201355","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"749_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2021.03.006","volume":"507","author":"S Mohajan","year":"2021","unstructured":"Mohajan S, Jaiswal PK, Vatanmakarian M, Yousefi H, Sankaralingam S, Alahari SK, Koul S, Koul HK (2021) Hippo pathway: regulation, deregulation and potential therapeutic targets in cancer. Cancer Lett 507:112\u2013123","journal-title":"Cancer Lett"},{"key":"749_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","volume":"20","author":"IM Moya","year":"2019","unstructured":"Moya IM, Halder G (2019) Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol 20:211\u2013226","journal-title":"Nat Rev Mol Cell Biol"},{"key":"749_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF (2021) Trends in peptide drug discovery. Nat Rev Drug Discov 20:309\u2013325","journal-title":"Nat Rev Drug Discov"},{"key":"749_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29684-9","volume":"13","author":"JK Nelson","year":"2022","unstructured":"Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, Legrave N, Koenis DS, Koifman G, Sugimoto Y et al (2022) USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun 13:2070","journal-title":"Nat Commun"},{"key":"749_CR29","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1101\/gad.264929.115","volume":"29","author":"L Ni","year":"2015","unstructured":"Ni L, Zheng Y, Hara M, Pan D, Luo X (2015) Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling. Genes Dev 29:1416\u20131431","journal-title":"Genes Dev"},{"key":"749_CR30","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/biom10111548","volume":"10","author":"CA Ni\u00f1o","year":"2020","unstructured":"Ni\u00f1o CA, Wollscheid N, Giangreco G, Maspero E, Polo S (2020) USP25 regulates EGFR fate by modulating EGF-induced ubiquitylation dynamics. Biomolecules 10:1548","journal-title":"Biomolecules"},{"key":"749_CR31","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1073\/pnas.1517188113","volume":"113","author":"M Nishio","year":"2016","unstructured":"Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, Takano Y, Hikasa H, Itoh T, Suzuki SO et al (2016) Dysregulated YAP1\/TAZ and TGF-\u03b2 signaling mediate hepatocarcinogenesis in Mob1a\/1b-deficient mice. Proc Natl Acad Sci USA 113:E71\u2013E80","journal-title":"Proc Natl Acad Sci USA"},{"key":"749_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jhep.2018.05.008","volume":"69","author":"SH Oh","year":"2018","unstructured":"Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, Diehl AM (2018) Liver regeneration requires Yap1-TGF\u03b2-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 69:359\u2013367","journal-title":"J Hepatol"},{"key":"749_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19:491\u2013505","journal-title":"Dev Cell"},{"key":"749_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1053\/j.gastro.2016.10.047","volume":"152","author":"SH Patel","year":"2017","unstructured":"Patel SH, Camargo FD, Yimlamai D (2017) Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology 152:533\u2013545","journal-title":"Gastroenterology"},{"key":"749_CR35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20:1242\u20131253","journal-title":"Nat Med"},{"key":"749_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cub.2008.02.006","volume":"18","author":"M Praskova","year":"2008","unstructured":"Praskova M, Xia F, Avruch J (2008) MOBKL1A\/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 18:311\u2013321","journal-title":"Curr Biol"},{"key":"749_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2045-3701-3-31","volume":"3","author":"F Qin","year":"2013","unstructured":"Qin F, Tian J, Zhou D, Chen L (2013) Mst1 and Mst2 kinases: regulations and diseases. Cell Biosci 3:31","journal-title":"Cell Biosci"},{"key":"749_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","volume":"19","author":"JO Russell","year":"2022","unstructured":"Russell JO, Camargo FD (2022) Hippo signalling in the liver: role in development, regeneration and disease. Nat Rev Gastroenterol Hepatol 19:297\u2013312","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"749_CR39","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.4161\/cc.26672","volume":"12","author":"Z Salah","year":"2013","unstructured":"Salah Z, Cohen S, Itzhaki E, Aqeilan RI (2013) NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. Cell Cycle 12:3817\u20133823","journal-title":"Cell Cycle"},{"key":"749_CR40","doi-asserted-by":"publisher","first-page":"G493","DOI":"10.1152\/ajpgi.00056.2011","volume":"302","author":"S Septer","year":"2012","unstructured":"Septer S, Edwards G, Gunewardena S, Wolfe A, Li H, Daniel J, Apte U (2012) Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. Am J Physiol Gastrointest Liver Physiol 302:G493\u2013G503","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"749_CR41","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1038\/s41388-020-1253-0","volume":"39","author":"N Shibata","year":"2020","unstructured":"Shibata N, Ohoka N, Tsuji G, Demizu Y, Miyawaza K, Ui-Tei K, Akiyama T, Naito M (2020) Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells. Oncogene 39:3867\u20133878","journal-title":"Oncogene"},{"key":"749_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/s12276-020-0483-0","volume":"52","author":"J So","year":"2020","unstructured":"So J, Kim A, Lee SH, Shin D (2020) Liver progenitor cell-driven liver regeneration. Exp Mol Med 52:1230\u20131238","journal-title":"Exp Mol Med"},{"key":"749_CR43","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/cancers11091362","volume":"11","author":"S Suemura","year":"2019","unstructured":"Suemura S, Kodama T, Myojin Y, Yamada R, Shigekawa M, Hikita H, Sakamori R, Tatsumi T, Takehara T (2019) CRISPR loss-of-function screen identifies the hippo signaling pathway as the mediator of regorafenib efficacy in hepatocellular carcinoma. Cancers 11:1362","journal-title":"Cancers"},{"key":"749_CR44","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13402-021-00595-z","volume":"44","author":"T Sun","year":"2021","unstructured":"Sun T, Mao W, Peng H, Wang Q, Jiao L (2021) YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin. Cell Oncol 44:689\u2013699","journal-title":"Cell Oncol"},{"key":"749_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","volume":"127","author":"X Sun","year":"2018","unstructured":"Sun X, Kaufman PD (2018) Ki-67: more than a proliferation marker. Chromosoma 127:175\u2013186","journal-title":"Chromosoma"},{"key":"749_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13591-7","volume":"10","author":"F Tang","year":"2019","unstructured":"Tang F, Gao R, Jeevan-Raj B, Wyss CB, Kalathur RKR, Piscuoglio S, Ng CKY, Hindupur SK, Nuciforo S, Dazert E et al (2019) LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function. Nat Commun 10:5755","journal-title":"Nat Commun"},{"key":"749_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter FP et al (2020) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther 5:87","journal-title":"Signal Transduct Target Ther"},{"key":"749_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4256352","volume":"2017","author":"Y Tao","year":"2017","unstructured":"Tao Y, Wang M, Chen E, Tang H (2017) Liver Regeneration: analysis of the main relevant signaling molecules. Mediators Inflamm 2017:4256352","journal-title":"Mediators Inflamm"},{"key":"749_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","volume":"7","author":"L Wang","year":"2022","unstructured":"Wang L, Wang N, Zhang W, Cheng X, Yan Z, Shao G, Wang X, Wang R, Fu C (2022) Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther 7:48","journal-title":"Signal Transduct Target Ther"},{"key":"749_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1281-7","volume":"10","author":"H Wu","year":"2019","unstructured":"Wu H, Zhang W, Wu Z, Liu Y, Shi Y, Gong J, Shen W, Liu C (2019) miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma. Cell Death Dis 10:48","journal-title":"Cell Death Dis"},{"key":"749_CR51","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.3390\/cancers13246214","volume":"13","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Dong J (2021) The hippo signaling pathway in cancer: a cell cycle perspective. Cancers 13:6214","journal-title":"Cancers"},{"key":"749_CR52","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye B, Zhou H, Chen Y, Luo W, Lin W, Zhao Y, Han J, Han X, Huang W, Wu G et al (2023) USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res 132:465\u2013480","journal-title":"Circ Res"},{"key":"749_CR53","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/hep.28768","volume":"64","author":"J Yi","year":"2016","unstructured":"Yi J, Lu L, Yanger K, Wang W, Sohn BH, Stanger BZ, Zhang M, Martin JF, Ajani JA, Chen J et al (2016) Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology 64:1757\u20131772","journal-title":"Hepatology"},{"key":"749_CR54","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","volume":"157","author":"D Yimlamai","year":"2014","unstructured":"Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD (2014) Hippo pathway activity influences liver cell fate. Cell 157:1324\u20131338","journal-title":"Cell"},{"key":"749_CR55","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jhep.2015.07.008","volume":"63","author":"D Yimlamai","year":"2015","unstructured":"Yimlamai D, Fowl BH, Camargo FD (2015) Emerging evidence on the role of the Hippo\/YAP pathway in liver physiology and cancer. J Hepatol 63:1491\u20131501","journal-title":"J Hepatol"},{"key":"749_CR56","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3892\/or.2017.5772","volume":"38","author":"H Zhang","year":"2017","unstructured":"Zhang H, Liu H, Bi H (2017) MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1. Oncol Rep 38:843\u2013849","journal-title":"Oncol Rep"},{"key":"749_CR57","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1016\/j.csbj.2023.08.003","volume":"21","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Hu W, Xiong L, Wen J, Wei T, Yan L, Liu Q, Zhu S, Bai Y, Zeng Y et al (2023) IHGA: An interactive web server for large-scale and comprehensive discovery of genes of interest in hepatocellular carcinoma. Comput Struct Biotechnol J 21:3987\u20133998","journal-title":"Comput Struct Biotechnol J"},{"key":"749_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ceb.2019.07.006","volume":"61","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhou D (2019) Role of the transcriptional coactivators YAP\/TAZ in liver cancer. Curr Opin Cell Biol 61:64\u201371","journal-title":"Curr Opin Cell Biol"},{"key":"749_CR59","doi-asserted-by":"publisher","first-page":"ra35","DOI":"10.1126\/scisignal.2003708","volume":"6","author":"B Zhong","year":"2013","unstructured":"Zhong B, Liu X, Wang X, Liu X, Li H, Darnay BG, Lin X, Sun SC, Dong C (2013) Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3. Sci Signal 6:ra35","journal-title":"Sci Signal"},{"key":"749_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","volume":"16","author":"D Zhou","year":"2009","unstructured":"Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J et al (2009) Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16:425\u2013438","journal-title":"Cancer Cell"},{"key":"749_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0898-7","volume":"19","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Wang Y, Zhou W, Chen T, Wu Q, Chutturghoon VK, Lin B, Geng L, Yang Z, Zhou L et al (2019) YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway. Cancer Cell Int 19:179","journal-title":"Cancer Cell Int"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00749-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-026-00749-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00749-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:35:49Z","timestamp":1779122149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-026-00749-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,13]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1038\/s44319-026-00749-w","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}